Literature DB >> 4283768

Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity.

M K Jasani, W W Downie, B M Samuels, W W Buchanan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4283768      PMCID： PMC1031152          DOI： 10.1136/ard.27.5.457

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  IBUFENAC IN THE TREATMENT OF ARTHRITIS.

Authors:  M THOMPSON; P STEPHENSON; J S PERCY
Journal:  Ann Rheum Dis       Date:  1964-09       Impact factor: 19.103

2.  CLINICAL TRIALS OF A NEW DRUG, IBUFENAC, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A PRELIMINARY REPORT.

Authors:  T M CHALMERS
Journal:  Ann Rheum Dis       Date:  1963-09       Impact factor: 19.103

3.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

4.  A modification of the hemagglutination test for rheumatoid arthritis.

Authors:  G HELLER; A S JACOBSON; M H KOLODNY
Journal:  Proc Soc Exp Biol Med       Date:  1949-11

5.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

6.  Some biological properties of 2-(4-isoburylphenyl)-propionic acid.

Authors:  S S Adams; E E Cliffe; B Lessel; J S Nicholson
Journal:  J Pharm Sci       Date:  1967-12       Impact factor: 3.534
  6 in total
  11 in total

1.  Non-steroid anti-inflammatory agents.

Authors: 
Journal:  Br Med J       Date:  1970-08-22

2.  Ocular side-effects of Ibuprofen.

Authors:  L M Collum; D I Bowen
Journal:  Br J Ophthalmol       Date:  1971-07       Impact factor: 4.638

3.  Ibuprofen hypersensitivity in systemic lupus erythematosus.

Authors:  M Sonnenblick; A S Abraham
Journal:  Br Med J       Date:  1978-03-11

Review 4.  Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders.

Authors:  E F Davies; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche; H K Johansen
Journal:  BMJ       Date:  1998-03-14

6.  COX-2 chronology.

Authors:  C J Hawkey
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 7.  Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

Authors:  P C Gotzsche; H K Johansen
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 8.  The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses.

Authors:  William G Dixon; Samy Suissa; Marie Hudson
Journal:  Arthritis Res Ther       Date:  2011-08-31       Impact factor: 5.156

Review 9.  Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.

Authors:  Inger L Meek; Mart A F J Van de Laar; Harald E Vonkeman
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-07

Review 10.  What the dental practitioner needs to know about pharmaco-therapeutic modalities of COVID-19 treatment: A review.

Authors:  Najla Dar-Odeh; Shadia Elsayed; Hamzah Babkair; Shaden Abu-Hammad; Nebras Althagafi; Rayan Bahabri; Yasmin Salah Eldeen; Wejdan Aljohani; Osama Abu-Hammad
Journal:  J Dent Sci       Date:  2020-11-19       Impact factor: 2.080
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.